These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9242509

  • 1. Mutational analysis of copper binding by human tyrosinase.
    Spritz RA, Ho L, Furumura M, Hearing VJ.
    J Invest Dermatol; 1997 Aug; 109(2):207-12. PubMed ID: 9242509
    [Abstract] [Full Text] [Related]

  • 2. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS, King RA.
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [Abstract] [Full Text] [Related]

  • 3. Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities.
    Noh H, Lee SJ, Jo HJ, Choi HW, Hong S, Kong KH.
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):726-732. PubMed ID: 32180482
    [Abstract] [Full Text] [Related]

  • 4. Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.
    Oetting WS, King RA.
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):274-8. PubMed ID: 1292009
    [Abstract] [Full Text] [Related]

  • 5. Computational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence.
    Hassan M, Abbas Q, Raza H, Moustafa AA, Seo SY.
    Mol Biosyst; 2017 Jul 25; 13(8):1534-1544. PubMed ID: 28640309
    [Abstract] [Full Text] [Related]

  • 6. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
    Oetting WS, Fryer JP, King RA.
    Hum Mutat; 1998 Jul 25; 12(6):433-4. PubMed ID: 10671066
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone.
    Ismaya WT, Rozeboom HJ, Weijn A, Mes JJ, Fusetti F, Wichers HJ, Dijkstra BW.
    Biochemistry; 2011 Jun 21; 50(24):5477-86. PubMed ID: 21598903
    [Abstract] [Full Text] [Related]

  • 8. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA, Mentink MM, Oetting WS.
    Mol Biol Med; 1991 Feb 21; 8(1):19-29. PubMed ID: 1943686
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS, King RA.
    Hum Genet; 1992 Nov 21; 90(3):258-62. PubMed ID: 1487241
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of copper uptake by tyrosinase from Bacillus megaterium.
    Kanteev M, Goldfeder M, Chojnacki M, Adir N, Fishman A.
    J Biol Inorg Chem; 2013 Dec 21; 18(8):895-903. PubMed ID: 24061559
    [Abstract] [Full Text] [Related]

  • 11. A three-dimensional model of mammalian tyrosinase active site accounting for loss of function mutations.
    Schweikardt T, Olivares C, Solano F, Jaenicke E, García-Borrón JC, Decker H.
    Pigment Cell Res; 2007 Oct 21; 20(5):394-401. PubMed ID: 17850513
    [Abstract] [Full Text] [Related]

  • 12. Conformation-dependent post-translational glycosylation of tyrosinase. Requirement of a specific interaction involving the CuB metal binding site.
    Olivares C, Solano F, García-Borrón JC.
    J Biol Chem; 2003 May 02; 278(18):15735-43. PubMed ID: 12595535
    [Abstract] [Full Text] [Related]

  • 13. Identification of active site residues involved in metal cofactor binding and stereospecific substrate recognition in Mammalian tyrosinase. Implications to the catalytic cycle.
    Olivares C, García-Borrón JC, Solano F.
    Biochemistry; 2002 Jan 15; 41(2):679-86. PubMed ID: 11781109
    [Abstract] [Full Text] [Related]

  • 14. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA, Pietsch J, Fryer JP, Savage S, Brott MJ, Russell-Eggitt I, Summers CG, Oetting WS.
    Hum Genet; 2003 Nov 15; 113(6):502-13. PubMed ID: 13680365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA.
    Am J Med Genet; 1992 Jul 15; 43(5):865-71. PubMed ID: 1642278
    [Abstract] [Full Text] [Related]

  • 17. Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis.
    Matoba Y, Kumagai T, Yamamoto A, Yoshitsu H, Sugiyama M.
    J Biol Chem; 2006 Mar 31; 281(13):8981-90. PubMed ID: 16436386
    [Abstract] [Full Text] [Related]

  • 18. First structures of an active bacterial tyrosinase reveal copper plasticity.
    Sendovski M, Kanteev M, Ben-Yosef VS, Adir N, Fishman A.
    J Mol Biol; 2011 Jan 07; 405(1):227-37. PubMed ID: 21040728
    [Abstract] [Full Text] [Related]

  • 19. The tyrosinase gene in gorillas and the albinism of 'Snowflake'.
    Martínez-Arias R, Comas D, Andrés A, Abelló MT, Domingo-Roura X, Bertranpetit J.
    Pigment Cell Res; 2000 Dec 07; 13(6):467-70. PubMed ID: 11153699
    [Abstract] [Full Text] [Related]

  • 20. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS, King RA.
    Hum Mutat; 1993 Dec 07; 2(1):1-6. PubMed ID: 8477259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.